![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without C... Read more
26 Jul 2023
•
36mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
24 Jul 2023
•
22mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
18 Jul 2023
•
16mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Joe O'Sullivan, MD, PhD, FRCR - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
Joe O'Sullivan, MD, PhD, FRCR - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
Joe O'Sullivan, MD, PhD, FRCR - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical ... Read more
18 Jul 2023
•
8mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
19 Jun 2023
•
25mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers
Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers
Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers
13 Jun 2023
•
20mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
James F. Howard Jr, MD - Complement-Mediated Attack of the Neuromuscular Junction in gMG: The C5 Inhibitors
James F. Howard Jr, MD - Complement-Mediated Attack of the Neuromuscular Junction in gMG: The C5 Inhibitors
James F. Howard Jr, MD - Complement-Mediated Attack of the Neuromuscular Junction in gMG: The C5 Inhibitors
31 May 2023
•
30mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?
Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?
Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?
12 May 2023
•
19mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
5 May 2023
•
24mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL2NsaW5pY2FsX3BoYXJtYWNvbG9neV9hdWRpby5qcGc=.jpg)
Stefano Fanti, MD - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
Stefano Fanti, MD - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
Stefano Fanti, MD - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up Fro... Read more
19 Apr 2023
•
11mins